Navigation Links
Unchecked Spread of HIV/AIDS May Impact Eco Growth: UN Report

India's achievements in various fields, particularly in terms of economic growth, could take a severe beating if HIV/AIDS continues its unchecked march in the country, a UN report said here today. //

The study based on the computable general equilibrium (CGE) analysis of the likely impact of the epidemic over a 14-year period between 2002-03 and 2015-16 showed that with the rapid spread of HIV/AIDS, the country's economic growth over the next 10-15 years would be noticeably less than its potential.

"Economic growth could decline by 0.86 percentage points over the period and per capita gross domestic product (GDP) by 0.55 percentage points," said the study conducted by National Council of Applied Economic Research (NCAER) and supported by the National AIDS Control Organisation (NACO) and the United Nations Development Programme (UNDP).

According to the projections made using the CGE model, the country's GDP, at 2002-03 prices, would decline in 2015-16 by Rs 7610.61, the report said.

It said that the increase in health spending by both, households and government, would lead to a fall in their savings, which then crowds out investment and causes growth to slow down.

The epidemic could also pull down incomes of HIV households by 9.24 per cent, which in turn could have an adverse impact on the economy, in terms of reduced savings and investments, the report said.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Unchecked Cellular Repair Pathway Causes Liver Cancer
2. Spreading its wings
3. Smallpox Would Spread Rapidly
4. Spreading knowledge to doctors about herbal medicine
5. Stopping Prostate Cancer from Spreading
6. Drug might prevent Prostate Cancer Spread
7. Circumcision Found To Prevent HIV Spread
8. New Way to Detect Spread of Skin Cancer
9. The Logic Behind The Spread Of SARS
10. Vaccine To Stop the Spread of Chickenpox
11. Minimizing The Risk Of HIV Spread
Post Your Comments:
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 1Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 2Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 3Mercy Health Plans Receives Five Star Excellent Rating 61479 1Mercy Health Plans Receives Five Star Excellent Rating 61479 2Vibrations key to efficiency of green fluorescent protein 14861 1Vibrations key to efficiency of green fluorescent protein 14861 2Vibrations key to efficiency of green fluorescent protein 14861 3Vibrations key to efficiency of green fluorescent protein 14861 4